Revolutionizing Parkinson's treatment: Harnessing the potential of intranasal nanoemulsions for targeted therapy

被引:2
作者
Sharma, Gulshan [1 ]
Wadhwa, Karan [2 ]
Kumar, Shobhit [3 ]
Singh, Govind [2 ]
Pahwa, Rakesh [1 ]
机构
[1] Kurukshetra Univ, Inst Pharmaceut Sci, Kurukshetra 136119, Haryana, India
[2] Maharshi Dayanand Univ, Dept Pharmaceut Sci, Rohtak 124001, Haryana, India
[3] Meerut Inst Engn & Technol MIET, Dept Pharmaceut Technol, NH-58 Delhi-Roorkee Highway, Meerut 250005, India
关键词
Parkinson's disease; Blood-brain barrier; Intranasal delivery; Nanoemulsion; Brain targeting; CENTRAL-NERVOUS-SYSTEM; BLOOD-BRAIN-BARRIER; DRUG-DELIVERY; MUCOADHESIVE NANOEMULSION; FORMULATION DEVELOPMENT; LIPID NANOPARTICLES; DIRECT NOSE; IN-VITRO; NANOFORMULATION; STRATEGIES;
D O I
10.1007/s13346-024-01770-z
中图分类号
TH7 [仪器、仪表];
学科分类号
0804 ; 080401 ; 081102 ;
摘要
Parkinson's disease (PD) is the most prominent and highly prevalent chronic neuro-degenerative disease generally recognized by classical motor symptoms which are linked with genetic mutation, Lewy bodies, and subsequently selective loss of nigrostriatal dopaminergic neurons. The blood-brain barrier (BBB) and blood-cerebrospinal fluid barrier protect the central nervous system against toxins and are the most significant barriers to effective brain drug delivery in managing Parkinsonism. In recent years, intranasal delivery has attracted remarkable attention for brain targeting as the drug can be administered to the brain directly from the nose employing the trigeminal and olfactory pathways. For brain targeting through nasal delivery, several advanced and promising formulation techniques have been investigated globally. Nanoemulsions are regarded as an innovative carrier approach for PD, where these provide targeted administration and enhanced bioavailability of neurotherapeutics. This manuscript provides deeper insight into the pathophysiology of PD, various drug delivery strategies to overcome BBB, and the potential role of nanoemulsions via the intranasal route. Various research findings on the intranasal administration of nanoemulsions and their pivotal applications in the treatment of PD have also been embarked. The potential role of phytoconstituents and surface-modified nanoemulsions for the effective treatment of PD has also been reflected along with current challenges and future perspectives in this avenue.
引用
收藏
页码:2589 / 2607
页数:19
相关论文
共 156 条
[1]   Nose-to-brain drug delivery: An update on clinical challenges and progress towards approval of anti-Alzheimer drugs [J].
Agrawal, Mukta ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Antimisiaris, Sophia G. ;
Chougule, Mahavir Bhupal ;
Shoyele, Sunday A. ;
Alexander, Amit .
JOURNAL OF CONTROLLED RELEASE, 2018, 281 :139-177
[2]   Recent advancements in the field of nanotechnology for the delivery of anti-Alzheimer drug in the brain region [J].
Agrawal, Mukta ;
Saraf, Swarnlata ;
Saraf, Shailendra ;
Antimisiaris, Sophia G. ;
Hamano, Nobuhito ;
Li, Shyh-Dar ;
Chougule, Mahavir ;
Shoyele, Sunday A. ;
Gupta, Umesh ;
Ajazuddin ;
Alexander, Amit .
EXPERT OPINION ON DRUG DELIVERY, 2018, 15 (06) :589-617
[3]   Evidence of nose-to-brain delivery of nanoemulsions: cargoes but not vehicles [J].
Ahmad, Ejaj ;
Feng, Yunhai ;
Qi, Jianping ;
Fan, Wufa ;
Ma, Yuhua ;
He, Haisheng ;
Xia, Fei ;
Dong, Xiaochun ;
Zhao, Weili ;
Lu, Yi ;
Wu, Wei .
NANOSCALE, 2017, 9 (03) :1174-1183
[4]   RETRACTED: Intranasal delivery of quercetin-loaded mucoadhesive nanoemulsion for treatment of cerebral ischaemia (Retracted Article) [J].
Ahmad, Niyaz ;
Ahmad, Rizwan ;
Naqvi, Atta Abbas ;
Alam, Md Aftab ;
Ashafaq, Mohammad ;
Rub, Rehan Abdur ;
Ahmad, Farhan Jalees .
ARTIFICIAL CELLS NANOMEDICINE AND BIOTECHNOLOGY, 2018, 46 (04) :717-729
[5]   Nose-to-Brain Delivery of Therapeutic Peptides as Nasal Aerosols [J].
Alabsi, Wafaa ;
Eedara, Basanth Babu ;
Encinas-Basurto, David ;
Polt, Robin ;
Mansour, Heidi M. .
PHARMACEUTICS, 2022, 14 (09)
[6]   Strategy for effective brain drug delivery [J].
Alam, M. Intakhab ;
Beg, Sarwar ;
Samad, Abdus ;
Baboota, Sanjula ;
Kohli, Kanchan ;
Ali, Javed ;
Ahuja, Alka ;
Akbar, M. .
EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2010, 40 (05) :385-403
[7]   Oral and Intra-nasal Administration of Nanoparticles in the Cerebral Ischemia Treatment in Animal Experiments: Considering its Advantages and Disadvantages open access plus [J].
Alavian, Firoozeh ;
Shams, Nasrin .
CURRENT CLINICAL PHARMACOLOGY, 2020, 15 (01) :20-29
[8]  
Alexander A, 2020, NANOPHARMACEUTICALS, VOL. 1, P175, DOI 10.1016/B978-0-12-817778-5.00009-9
[9]   Recent expansions of novel strategies towards the drug targeting into the brain [J].
Alexander, Amit ;
Agrawal, Mukta ;
Uddin, Ajaz ;
Siddique, Sabahuddin ;
Shehata, Ahmed M. ;
Shaker, Mahmoud A. ;
Rahman, Syed Ata Ur ;
Abdul, Mohi Iqbal M. ;
Shaker, Mohamed A. .
INTERNATIONAL JOURNAL OF NANOMEDICINE, 2019, 14 :5895-5909
[10]   Recent advances towards overcoming the blood-brain barrier [J].
Ali, Amna ;
Arshad, Muhammad Sohail ;
Khan, Mahtab Ahmad ;
Chang, Ming-Wei ;
Ahmad, Zeeshan .
DRUG DISCOVERY TODAY, 2023, 28 (10)